Skip to main content

Hyaluronic Acid

No sources yet

An index of captured practitioner sources, not a completed evidence summary. Unchecked figures and empty sections are omitted. See the library review status.

Source summary generated November 6, 2026; this date does not indicate completed review.

Tissue researchAliases: HA, hyaluronan, sodium hyaluronate
Track your own protocol free →

Quotes from three independent practitioners, with their sources. Research context only.

What it is and how it works

From the published literature on Hyaluronic Acid; the papers are listed at the end. Research summary, not a recommendation.

What it is

Hyaluronic acid (hyaluronan) is a long, unbranched sugar-based molecule (a glycosaminoglycan) made of repeating pairs of N-acetylglucosamine and glucuronic acid. It occurs throughout the bodies of humans and other vertebrates and was first isolated in 1934. It is not a peptide. In medicine it is used mainly in two injected forms: cross-linked gels used as dermal (skin) fillers, and joint injections called viscosupplementation.

How it works

Hyaluronic acid binds a large amount of water and is viscous and elastic, which is why it gives volume to skin and acts as a lubricating, shock-absorbing fluid in joints. A review of its biology describes roles in cell signaling, wound repair and tissue organization through cell receptors such as CD44, with the body breaking it down using enzymes called hyaluronidases. The review also describes chemical cross-linking and other modifications used to customize its properties for medical products.

What it has been studied for

  • Facial wrinkles, folds and volume loss as an injectable dermal filler (randomized trials and safety reviews)
  • Pain and function in knee osteoarthritis as a joint injection (meta-analyses)
  • Wound repair, drug delivery and other uses (review)

Strength of the evidence

Approved drugFDA-approved hyaluronic acid products exist, regulated as medical-device implants (the 2024 survey found 28 filler products), backed by randomized trials and meta-analyses.

What the literature reports on safety

The FDA states that dermal fillers are approved medical-device implants for adults, that the main risk is injection into a blood vessel (vascular occlusion), and that complications can include tissue death, vision loss including blindness, and stroke; it warns that no filler is approved for over-the-counter use and that fillers bought online risk being counterfeit or unapproved. A systematic review of randomized trials found most filler side effects were short-lived injection-site reactions, with severe events rare. For knee injections, a 2022 meta-analysis found only a small pain benefit below the clinically important threshold and a higher risk of serious adverse events than placebo.

Key papers

  1. Hyaluronic Acid in the Third Millennium. (opens in a new tab)

    Review · Fallacara A, Baldini E, et al. · Polymers (2018) · PMID 30960626

    Reviewed the structure, biology, receptors, degradation and uses of hyaluronic acid from its 1934 isolation to modern medical, pharmaceutical and cosmetic applications.

  2. Current Landscape of Hyaluronic Acid Filler Use in the United States. (opens in a new tab)

    Review · Shah R, Matarasso S, et al. · Journal of Drugs in Dermatology (2024) · PMID 38206154

    Searched the FDA premarket approval database and identified 28 FDA-approved hyaluronic acid dermal fillers, listing their properties and indications.

  3. Adverse Events Associated with Hyaluronic Acid Filler Injection for Non-surgical Facial Aesthetics: A Systematic Review of High Level of Evidence Studies. (opens in a new tab)

    Review · Kyriazidis I, Spyropoulou GA, et al. · Aesthetic Plastic Surgery (2024) · PMID 37563436

    In 48 randomized studies, most filler adverse events were short injection-site reactions that resolved on their own, and severe events were rare.

  4. Viscosupplementation for the treatment of osteoarthritis of the knee. (opens in a new tab)

    Review · Bellamy N, Campbell J, et al. · Cochrane Database of Systematic Reviews (2006) · PMID 16625635

    Pooled randomized trials found beneficial effects on pain, function and global assessment, strongest 5 to 13 weeks after injection, with effect size varying by product.

  5. Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis. (opens in a new tab)

    Review · Pereira TV, Jüni P, et al. · BMJ (2022) · PMID 36333100

    In 169 trials, viscosupplementation gave a small pain reduction below the clinically important difference and a higher risk of serious adverse events than placebo, and the authors did not support broad use.

Sources checked: PubMed (E-utilities abstracts for every PMID), FDA dermal fillers page (fda.gov, medical devices), written 2026-11-06.

No sources yet

None of the three teachers' sources we have indexed discuss Hyaluronic Acid yet. This page will fill in as sources are added.

Deeper guided audio lives on What Am I Appreciating Now (leaves this site, opens in a new tab). What Am I Appreciating Now is a separate site run by the same operator; it sells meditation and hypnosis sessions.

Disclaimer: for research purposes only

All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.

Hyaluronic Acid — Hunter, Taylor, Bachmeyer | Reset Biology